Solesence (SLSN)
Nasdaq Market Open
Solesence, Inc. is a science-led skin health and beauty company focused on mineral-based sun protection, skin care, and wellness applications. The business develops and supplies formulations and active ingredients intended to combine ultraviolet protection with cosmetic elegance, an important requirement in prestige skin care and daily-use sun care products.
The company’s core offering is built around proprietary mineral UV-protection technology. Its products include fully developed skin care formulations that use mineral active pharmaceutical ingredients, as well as active ingredients sold to other manufacturers for use in sunscreens, daily care products, and related skin health applications. This positions Solesence at the intersection of consumer beauty, dermatology-oriented wellness, and specialty materials science.
Solesence serves markets where product feel, transparency, stability, and regulatory compliance are key considerations. Mineral sunscreen ingredients such as zinc oxide and titanium dioxide are widely used in sun protection, but formulation challenges can include whitening, texture, dispersion, and compatibility with other cosmetic ingredients. The company’s technology is aimed at helping brands address those challenges while meeting demand for health-oriented and multifunctional skin care.
In addition to its skin health focus, Solesence continues to participate in legacy specialty materials markets. These include medical diagnostics, architectural and industrial coatings, abrasion-resistant additives, and plastics-related applications. Those activities reflect the company’s broader materials expertise, although its strategic emphasis is on skin care, beauty, and wellness. Solesence reports its operations as a single business segment, meaning its financial results are presented as one integrated operating business rather than separate divisions.
Last updated
- Market Cap
- 89M
- P/E
- 94.28
- P/FCF
- —
- P/S
- 1.47
- Enterprise Value
- 101.97M
- Sector
- —
- Industry
- Perfumes, Cosmetics, and Other Toilet Preparations
- Address
- 1319 MARQUETTE DRIVE, ROMEOVILLE, IL, 60446
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
Solésence Reports Third Quarter 2025 Financial Results
Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 89M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 101.97M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 94.28
- P/B
P/B ratio compares a company's share price to its book value per share.
- 5.25
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.47
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 56.81
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.69
- EPS
- 0.01
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 520.45
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -2.63M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 5.56%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 1.98%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.8
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.08
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.7
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.05
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 42.26K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 1.26
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|
| Revenue | 12.96M | 12.48M | 14.6M | 20.36M |
| Gross profit | 3.34M | 3.43M | 3.37M | 5.88M |
| Operating income | -504K | 186K | -781K | 1.91M |
| EBITDA | -191K | 407K | -556K | 2.14M |
| Net income | -766K | 163K | -1.12M | 2.67M |
| Basic EPS | -0.01 | 0.01 | -0.02 | 0.04 |
| Diluted EPS | -0.01 | 0 | -0.02 | 0.04 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|
| Total assets | 47.79M | 50.06M | 53.99M | 59.96M |
| Total liabilities | 30.83M | 32.42M | 36.76M | 41.77M |
| Total equity | 16.97M | 17.63M | 17.23M | 18.19M |
| Cash & equivalents | 573K | 1.29M | 429K | 4.11M |
| Current assets | 26.41M | 28.78M | 32.79M | 38.77M |
| Current liabilities | 12.69M | 13.93M | 17.86M | 22.54M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|
| Operating cash flow | 1.52M | 1.82M | -2.51M | -654K |
| Investing cash flow | -528K | -450K | -418K | -1.41M |
| Financing cash flow | -1.7M | -510K | -750K | 4.35M |
| Change in cash | -715K | 859K | -3.68M | 2.29M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| edgar index | 10-Q — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K/A — SOLESENCE, INC. | View Filing | |
| edgar index | 4 — SOLESENCE, INC. | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| edgar index | 4 — SOLESENCE, INC. | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| form 4 | Form 4 — WHITMORE R JANET | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — SOLESENCE, INC. | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 3 — SOLESENCE, INC. | View Filing | |
| form 3 | Form 3 — Riffner Laura C | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — SOLESENCE, INC. | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — SOLESENCE, INC. | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — SOLESENCE, INC. | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| form 4 | Form 4 — Cureton Kevin | View Filing | |
| edgar index | 4 — SOLESENCE, INC. | View Filing | |
| edgar index | SCHEDULE 13D/A — SOLESENCE, INC. | View Filing | |
| edgar index | 8-K — SOLESENCE, INC. | View Filing | |
| form 4 | Form 4 — WHITMORE BRADFORD T | View Filing | |
| form 4 | Form 4 — WHITMORE BRADFORD T | View Filing | |
| form 4 | Form 4 — WHITMORE BRADFORD T | View Filing | |
| form 4 | Form 4 — WHITMORE BRADFORD T | View Filing | |
| form 4 | Form 4 — WHITMORE BRADFORD T | View Filing | |
| form 4 | Form 4 — WHITMORE BRADFORD T | View Filing |